What are the typical transthoracic two-dimensional echocardiographic findings in a patient with rheumatic fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

2D Echocardiographic Findings in Rheumatic Heart Disease

The hallmark 2D echocardiographic findings in rheumatic heart disease include mitral valve leaflet thickening, restricted leaflet motion with the pathognomonic "hockey-stick" deformity of the anterior mitral leaflet, commissural fusion, and chordal thickening—features that distinguish rheumatic from other etiologies. 1, 2

Mitral Valve Findings (Primary Target)

The mitral valve is affected in virtually all cases of rheumatic heart disease, with 99.3% of echocardiographic cases and 100% of postmortem examinations showing mitral involvement. 1

Morphological Features

  • Leaflet thickening: Irregular or focal thickening of the mitral valve leaflets, particularly at the tips, is a cardinal feature that helps differentiate rheumatic from degenerative disease. 3, 2

  • Restricted leaflet motion with "hockey-stick" deformity: The anterior mitral leaflet demonstrates restricted mobility with characteristic diastolic doming, creating the pathognomonic "hockey-stick" appearance—this combination is virtually diagnostic of established rheumatic heart disease. 1, 2

  • Commissural fusion: Fusion at the commissures is a defining structural abnormality that distinguishes rheumatic mitral stenosis from degenerative mitral stenosis (which lacks commissural fusion). 3, 2, 4

  • Chordal thickening and fusion: Subvalvular apparatus involvement with thickened, shortened, and fused chordae tendineae is characteristic of chronic rheumatic disease. 1, 2, 4

  • Valvular nodules: Approximately 25% of patients with acute rheumatic carditis demonstrate focal valvular nodules on the body and tips of mitral leaflets—these likely represent echocardiographic equivalents of rheumatic verrucae and typically disappear on follow-up. 5

Functional Consequences

  • Mitral regurgitation: This is the most frequent finding, occurring in 87-94% of cases, with mechanisms including ventricular dilatation (54-74% of cases) and restricted leaflet mobility (37% of cases). 1, 5

  • Mitral stenosis: Results from the combination of commissural fusion, leaflet thickening, and restricted mobility, best assessed by 2D planimetry of the valve orifice area (though 3D planimetry provides more accurate measurements). 2, 4

Aortic Valve Findings (Secondary Target)

Morphological Features

  • Irregular or focal thickening: Aortic leaflet thickening occurs in 41-100% of individuals with rheumatic aortic regurgitation, commonly at the free edge of the leaflets, with higher prevalence in older patients. 3

  • Coaptation defect: Leaflet retraction and rolling of leaflet edges result in a characteristic central (often triangular-shaped) coaptation defect visible on 2D echocardiography. 3

  • Restricted leaflet motion: Found in 76% of patients with rheumatic aortic disease, corresponding to commissural fusion with or without associated thickening and calcification (fusion ranges from 11-73.8% in surgical series). 3

  • Prolapse or excessive leaflet motion: Aortic cusp tissue extending below the annular level occurs in 11% of acute rheumatic carditis cases, though this finding is not specific to rheumatic disease and requires clinical context for interpretation. 3

Tricuspid Valve Findings

  • Leaflet thickening: All patients with tricuspid valve involvement demonstrate thickened leaflets on echocardiography. 6

  • Doming, restricted motion, and calcification: These features occur in varying proportions when the tricuspid valve is organically involved, typically secondary to left-sided valve disease. 6

  • Tricuspid regurgitation and stenosis: Organic tricuspid involvement is not uncommon, though it receives less attention than left-sided disease. 6

Critical Diagnostic Considerations

The World Heart Federation criteria emphasize that these morphological features must be interpreted in clinical context, as they are not entirely unique to rheumatic disease. 3

Essential Exclusions

  • Congenital anomalies: Must rule out cleft mitral valve, double-orifice valve, or parachute variants before confirming rheumatic etiology. 1

  • Other etiologies: Degenerative disease, endocarditis, myxomatous degeneration, and functional regurgitation must be excluded through comprehensive echocardiographic and clinical assessment. 3

Common Pitfalls

  • Age-related variations: Commissural fusion and leaflet thickening are less frequent in children compared to adults, so absence of these features does not exclude acute rheumatic carditis in younger patients. 3

  • Acute versus chronic disease: In acute rheumatic carditis without prior valve disease, ventricular dilatation may be the primary mechanism of regurgitation rather than structural leaflet abnormalities, and valvular nodules may be transient. 5

  • Functional assessment: The majority of patients with rheumatic carditis have normal left ventricular systolic function; congestive heart failure occurs only when hemodynamically significant valve lesions are present. 5

References

Guideline

Echocardiographic Diagnosis of Rheumatic Mitral Valve Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Recommendations for the Use of Echocardiography in the Evaluation of Rheumatic Heart Disease: A Report from the American Society of Echocardiography.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the typical appearance on transthoracic echocardiography (TTE) in a patient with a history of acute rheumatic fever (ARF) and rheumatic heart disease (RHD) with mitral valve involvement?
What is the best imaging modality for diagnosing valvular defects in chronic Rheumatic Heart Disease (RHD)?
How does rheumatic fever present on echocardiography (echo)?
Is echocardiography necessary in the diagnosis of musculoskeletal (MSK) infections in the reproductive system?
What are the criteria for diagnosing Rheumatic Heart Disease (RHD)?
What is the mechanism of action of Trikafta (elexacaftor/tezacaftor/ivacaftor) in cystic fibrosis?
What is the appropriate treatment for opioid‑induced constipation in a patient taking opioid analgesics?
Does subcutaneous haloperidol provide antipsychotic efficacy comparable to intramuscular or oral administration?
Can medico‑legal liability be presumed for a woman who suffered a perinatal asphyxial event when placenta accreta was identified only at cesarean delivery, subclinical pre‑eclampsia worsened postpartum, and an undifferentiated connective‑tissue disease was diagnosed postpartum, due to failure to diagnose these conditions in a timely manner?
What is the appropriate treatment for an adult patient with irritable bowel syndrome with constipation (IBS‑C)?
What are the benefits, dosing recommendations, and safety considerations of Trikafta (elexacaftor/tezacaftor/ivacaftor) for cystic fibrosis patients aged ≥ 2 years with at least one F508del mutation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.